BC PharmaCare - Review of medications for COPD
Issued February 27, 2019 - Deadline March 27, 2019
The drugs included in this review are
• Aclidinium bromide (TUDORZA® GENUAIR®), by AstraZeneca Canada Inc.
• Aclidinium bromide-formoterol fumarate (DUAKLIR® GENUAIR®), by AstraZeneca Canada Inc.
• Beclomethasone dipropionate (QVAR™), by Valeant Canada LP
• Budesonide (PULMICORT® TURBUHALER®), by AstraZeneca Canada Inc.
• Budesonide-formoterol fumarate (SYMBICORT® TURBUHALER®), by AstraZeneca Canada
• Ciclesonide (ALVESCO®), by AstraZeneca Canada Inc.
• Fluticasone furoate (ARNUITY ELLIPTA), by GlaxoSmithKline Inc.(GSK)
• Fluticasone furoate-vilanterol (BREO ELLIPTA), by GlaxoSmithKline Inc.
• Fluticasone furoate-umeclidinium-vilanterol (TRELEGY ELLIPTA), by GlaxoSmithKline Inc.
• Fluticasone propionate
(FLOVENT HFA and FLOVENT DISKUS) by GSK Inc. and (AERMONY
RESPICLICKTM) by Teva Canada
• Fluticasone propionate-salmeterol (ADVAIR, ADVAIR DISKUS) by GSK Inc. and (ARBESDA RESPICLICKTM) by Teva Canada
• Formoterol fumarate (FORADIL) by Novartis Pharmaceuticals Canada Inc. and (OXEZE® TURBUHALER®) by AstraZeneca Canada Inc.
• Glycopyrronium bromide (SEEBRI® BREEZHALER®), by Novartis Pharmaceuticals Canada Inc.
• Indacaterol maleate (ONBREZ® BREEZHALER®), by Novartis Pharmaceuticals Canada Inc.
• Indacaterol-glycopyrronium (ULTIBRO® BREEZHALER®), by Novartis Pharmaceuticals Canada
• Mometasone furoate (ASMANEX® TWISTHALER®), by Merck Canada Inc.
• Mometasone furoate-formoterol (ZENHALE®), by Merck Canada Inc.
• Salmeterol xinafoate (SEREVENT® DISKHALER® and SEREVENT® DISKUS®), by GlaxoSmithKline Inc.
• Tiotropium (SPIRIVA® and SPIRIVA® RESPIMAT®), by Boehringer Ingelheim Canada Ltd.
• Tiotropium-olodaterol (INSPIOLTO™ RESPIMAT®), by Boehringer Ingelheim (Canada) Ltd.
• Umeclidinium (INCRUSE ELLIPTA), by GlaxoSmithKline Inc.
• Umeclidinium-vilanterol (ANORO ELLIPTA), by GlaxoSmithKline Inc
To receive the complete document from BC PharmaCare click on the image below:
